For research use only. Not for therapeutic Use.
Acetazolamide-d3 (CAS: 1189904-01-5), a premium pharmaceutical research compound designed for advanced studies in diuretics and carbonic anhydrase inhibitors. As a deuterated analog of Acetazolamide, it offers enhanced stability and improved pharmacokinetic properties. Acetazolamide-d3 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for glaucoma, altitude sickness, and certain types of edema. Trusted by leading laboratories, Acetazolamide-d3 is your go-to solution for cutting-edge diuretic and enzyme inhibition research. Unlock new possibilities in treatment with Acetazolamide-d3, where innovation meets reliability.
Catalog Number | S000179 |
CAS Number | 1189904-01-5 |
Molecular Formula | C4H3D3N4O3S2 |
Purity | ≥95% |
Target | Carbonic Anhydrase |
IUPAC Name | 2,2,2-trideuterio-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide |
InChI | InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)/i1D3 |
InChIKey | BZKPWHYZMXOIDC-FIBGUPNXSA-N |
SMILES | [2H]C([2H])([2H])C(=O)NC1=NN=C(S1)S(=O)(=O)N |